Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Join | Sign in
Home>News

  News Archive

Prof. Dr. Helga Rübsamen-Schaeff and Joerg von Petrikowsky Join 4SC AG
Saturday, January 17, 2015
Prof. Dr. Rübsamen-Schaeff and Mr. von Petrikowsky will replace the Supervisory Board members Dr. Thomas Werner and Klaus Kühn.

Lilly, Merck Enter Collaboration Agreement
Friday, January 16, 2015
Agreement to research immuno-oncology combination regimens in multiple types of cancer.

Dako, Cell Signalling Tech Partner with Companion Diagnostics
Monday, January 12, 2015
Partnership for development of high-quality, cutting-edge companion diagnostic products for diagnosis and treatment of cancer.

GRP78 Protein Possible Universal Therapeutic Target
Tuesday, January 06, 2015
Drug combination including Viagra is effective tool in targeting the protein.

Bad Luck of Random Mutations Plays Predominant Role in Cancer, Study Shows
Tuesday, January 06, 2015
Statistical modeling links cancer risk with number of stem cell divisions.

3-D Culture System for Pancreatic Cancer has Potential to Change Therapeutic Approaches
Tuesday, January 06, 2015
Organoid technology with human tissue provides a model for full progression of the disease.

Compugen Discloses Initial Experimental Results for Predicted ADC Targets
Tuesday, January 06, 2015
Pipeline program for oncology to be further expanded and diversified with addition of ADC therapeutic programs to ongoing immuno-oncology programs.

Targeting The Cell’s ‘Biological Clock’
Monday, January 05, 2015
Researchers target the cell’s ‘biological clock’ in promising new therapy to kill cancer cells, shrink tumor growth.

Oncodesign Enters into a Services Agreement with Eisai
Friday, December 26, 2014
The program aims to identify useful patient stratification biomarkers for Eisai’s Halaven® eribulin using patient-derived xenograft models.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 3329
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters